BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dimopoulou I, Pelekanou A, Mavrou I, Savva A, Tzanela M, Kotsaki A, Kardara M, Orfanos SE, Kotanidou A, Giamarellos-Bourboulis EJ. Early serum levels of soluble triggering receptor expressed on myeloid cells-1 in septic patients: correlation with monocyte gene expression. J Crit Care 2012;27:294-300. [PMID: 21855288 DOI: 10.1016/j.jcrc.2011.06.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Mihailidou I, Pelekanou A, Pistiki A, Spyridaki A, Tzepi IM, Damoraki G, Giamarellos-Bourboulis EJ. Dexamethasone Down-Regulates Expression of Triggering Receptor Expressed on Myeloid Cells-1: Evidence for a TNFα-Related Effect. Front Public Health 2013;1:50. [PMID: 24350219 DOI: 10.3389/fpubh.2013.00050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Georgescu AM, Grigorescu BL, Chirteș IR, Vitin AA, Fodor RȘ. The Relevance of Coding Gene Polymorphysms of Cytokines and Cellular Receptors in Sepsis. J Crit Care Med (Targu Mures) 2017;3:5-11. [PMID: 29967864 DOI: 10.1515/jccm-2017-0001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
3 Pelham CJ, Agrawal DK. Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases. Expert Rev Clin Immunol 2014;10:243-56. [PMID: 24325404 DOI: 10.1586/1744666X.2014.866519] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
4 Tzepi IM, Giamarellos-Bourboulis EJ, Carrer DP, Tsaganos T, Claus RA, Vaki I, Pelekanou A, Kotsaki A, Tziortzioti V, Topouzis S. Angiopoietin-2 enhances survival in experimental sepsis induced by multidrug-resistant Pseudomonas aeruginosa. J Pharmacol Exp Ther. 2012;343:278-287. [PMID: 22859861 DOI: 10.1124/jpet.112.195180] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
5 Cui N, Wang H, Su LX, Zhang JH, Long Y, Liu DW. Role of Triggering Receptor Expressed on Myeloid Cell-1 Expression in Mammalian Target of Rapamycin Modulation of CD8+ T-cell Differentiation during the Immune Response to Invasive Pulmonary Aspergillosis. Chin Med J (Engl) 2017;130:1211-7. [PMID: 28485322 DOI: 10.4103/0366-6999.205850] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
6 Aziz M, Jacob A, Yang WL, Matsuda A, Wang P. Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol 2013;93:329-42. [PMID: 23136259 DOI: 10.1189/jlb.0912437] [Cited by in Crossref: 177] [Cited by in F6Publishing: 165] [Article Influence: 17.7] [Reference Citation Analysis]
7 Bisson C, Massin F, Lefevre PA, Thilly N, Miller N, Gibot S. Increased gingival crevicular fluid levels of soluble triggering receptor expressed on myeloid cells (sTREM) -1 in severe periodontitis. J Clin Periodontol 2012;39:1141-8. [PMID: 23067264 DOI: 10.1111/jcpe.12008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
8 Dopheide JF, Rubrech J, Trumpp A, Geissler P, Zeller GC, Bock K, Dünschede F, Trinh TT, Dorweiler B, Münzel T, Radsak MP, Espinola-Klein C. Leukocyte-platelet aggregates-a phenotypic characterization of different stages of peripheral arterial disease. Platelets 2016;27:658-67. [PMID: 27352829 DOI: 10.3109/09537104.2016.1153619] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
9 Vázquez-Otero I, Rodríguez-Navedo Y, Vilá-Rivera K, Nieves-Plaza M, Morales-Ortiz J, Washington AV, Vilá LM. Association of soluble TREM-like transcript-1 with clinical features and patient reported outcomes in systemic lupus erythematosus. Eur J Rheumatol 2018;5:244-8. [PMID: 30308137 DOI: 10.5152/eurjrheum.2018.18074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Pelham CJ, Pandya AN, Agrawal DK. Triggering receptor expressed on myeloid cells receptor family modulators: a patent review. Expert Opin Ther Pat 2014;24:1383-95. [PMID: 25363248 DOI: 10.1517/13543776.2014.977865] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
11 Jiang J, Wang X, Cheng T, Han M, Wu X, Wan H, DaojunYu. Dynamic Monitoring of sTREM-1 and Other Biomarkers in Acute Cholangitis. Mediators Inflamm 2020;2020:8203813. [PMID: 32508526 DOI: 10.1155/2020/8203813] [Reference Citation Analysis]
12 Matos AO, Dantas PHDS, Silva-Sales M, Sales-Campos H. TREM-1 isoforms in bacterial infections: to immune modulation and beyond. Crit Rev Microbiol 2021;47:290-306. [PMID: 33522328 DOI: 10.1080/1040841X.2021.1878106] [Reference Citation Analysis]
13 Qian L, Weng XW, Chen W, Sun CH, Wu J. TREM-1 as a potential therapeutic target in neonatal sepsis. Int J Clin Exp Med 2014;7:1650-8. [PMID: 25126161] [Reference Citation Analysis]
14 Loughland JR, Woodberry T, Field M, Andrew DW, SheelaNair A, Dooley NL, Piera KA, Amante FH, Kenangalem E, Price RN, Engwerda CR, Anstey NM, McCarthy JS, Boyle MJ, Minigo G. Transcriptional profiling and immunophenotyping show sustained activation of blood monocytes in subpatent Plasmodium falciparum infection. Clin Transl Immunology 2020;9:e1144. [PMID: 32566226 DOI: 10.1002/cti2.1144] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 El Bakry SA, Bassyouni IH, El-shazly R, Abou-el Alla AA. Clinical significance of soluble-triggering receptor expressed on myeloid cells-1 (sTREM-1) in patients with rheumatoid arthritis. The Egyptian Rheumatologist 2013;35:95-100. [DOI: 10.1016/j.ejr.2012.11.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
16 Gao S, Yi Y, Xia G, Yu C, Ye C, Tu F, Shen L, Wang W, Hua C. The characteristics and pivotal roles of triggering receptor expressed on myeloid cells-1 in autoimmune diseases. Autoimmun Rev 2019;18:25-35. [PMID: 30408584 DOI: 10.1016/j.autrev.2018.07.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
17 Alexis A, Carrer D, Droggiti D, Louis K, Pistiki A, Netea MG, Kapessidou Y, Giamarellos-bourboulis EJ. Immune responses in relation to the type and time of thermal injury: An experimental study. Injury 2015;46:227-32. [DOI: 10.1016/j.injury.2014.10.057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
18 Tao F, Peng L, Li J, Shao Y, Deng L, Yao H. Association of serum myeloid cells of soluble triggering receptor-1 level with myocardial dysfunction in patients with severe sepsis. Mediators Inflamm 2013;2013:819246. [PMID: 23861562 DOI: 10.1155/2013/819246] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
19 Saldir M, Tunc T, Cekmez F, Cetinkaya M, Kalayci T, Fidanci K, Babacan O, Erdem G, Kocak N, Sari E, Akgul EO, Kul M. Endocan and Soluble Triggering Receptor Expressed on Myeloid Cells-1 as Novel Markers for Neonatal Sepsis. Pediatrics & Neonatology 2015;56:415-21. [DOI: 10.1016/j.pedneo.2015.03.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
20 Marioli A, Koupetori M, Raftogiannis M, Patrani M, Antonakos N, Pavlaki M, Adamis G, Dougekou G, Damoraki G, Tsangaris I. Early changes of the kinetics of monocyte trem-1 reflect final outcome in human sepsis. BMC Immunol 2014;15:585. [PMID: 25532536 DOI: 10.1186/s12865-014-0063-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
21 da Silva-Neto PV, de Carvalho JCS, Pimentel VE, Pérez MM, Toro DM, Fraga-Silva TFC, Fuzo CA, Oliveira CNS, Rodrigues LC, Argolo JGM, Carmona-Garcia I, Neto NT, Souza COS, Fernandes TM, Bastos VAF, Degiovani AM, Constant LF, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, da Rocha JJR, Feres O, Frantz FG, Gerlach RF, Maruyama SR, Russo EMS, Viana AL, Fernandes APM, Santos IKFM, Bonato VLD, Boechat AL, Malheiro A, Sadikot RT, Dias-Baruffi M, Cardoso CRB, Faccioli LH, Sorgi CA, On Behalf Of The Imunocovid Study Group. sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity. Viruses 2021;13:2521. [PMID: 34960790 DOI: 10.3390/v13122521] [Reference Citation Analysis]
22 Doughty C, O'Driscoll DN, Smith S, O'Currain E, Grant T, O'Hare FM, Culliton M, Watson RWG, O'Neill A, Molloy EJ. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in neonatal sepsis. J Matern Fetal Neonatal Med 2020;:1-8. [PMID: 32674630 DOI: 10.1080/14767058.2020.1786520] [Reference Citation Analysis]
23 Charles PE, Noel R, Massin F, Guy J, Bollaert PE, Quenot JP, Gibot S. Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis. BMC Infect Dis 2016;16:559. [PMID: 27729010 DOI: 10.1186/s12879-016-1893-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]